About DeckTherapeutics
DeckTherapeutics is a Healthcare company based in Albany (United States) founded in 2019. Drugs for traumatic brain injury and stroke are developed. DeckTherapeutics offers products and services including THDG3. Its focus areas include Life Sciences, Neurology, Drugs and Neural Injury. Its competitors include Tonix Pharma, Basking Biosciences and Neuraptive; 3 of its 3 listed competitors have raised funding.
Company details
DeckTherapeutics was founded in 2019 and is based in Albany, United States. Focus is placed on developing pharmaceutical treatments within the biotechnology sector for traumatic brain injury and acute ischemic stroke. A patented lipid-based molecule, naturally occurring in the brain, is utilized with a pleiotropic mechanism of action targeting multiple pathways rather than single targets. Operations center on drug innovation for neurological conditions.
- Headquarters Albany, United States
- SectorsHealthcare
- Website decktherapeutics.com
- Social LinkedIn
Products & Services of DeckTherapeutics
DeckTherapeutics offers a comprehensive portfolio of products and services, including THDG3.
Semi-synthetic omega-3 emulsion for treating hypoxic-ischemic brain injuries.
Competitors of DeckTherapeutics
DeckTherapeutics has 3 listed competitors in our database, 3 of them funded. They include Tonix Pharma, Basking Biosciences and Neuraptive.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tonixpharma.com | 2007 | New York, United States | $4.45M | 117 | Next-generation medicines for CNS and immunological disorders are developed. | |
| baskingbiosciences.com | 2019 | Columbus, United States | $89.8M | 3 | Therapeutics for ischemic stroke treatment are developed. | |
| neuraptive.com | 2016 | Lafayette, United States | $12.5M | Therapeutic solution for the repair of cut and crushed peripheral nerves. |
Detailed competitors of DeckTherapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as DeckTherapeutics (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Decktherapeutics
Complete news archive for DeckTherapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DeckTherapeutics
DeckTherapeutics was founded in 2019.
DeckTherapeutics is headquartered in Albany, United States.
DeckTherapeutics was founded in 2019 and is based in Albany, United States. Focus is placed on developing pharmaceutical treatments within the biotechnology sector for traumatic brain injury and acute ischemic stroke. A patented lipid-based molecule, naturally occurring in the brain, is utilized with a pleiotropic mechanism of action targeting multiple pathways rather than single targets. Operations center on drug innovation for neurological conditions.
DeckTherapeutics's top competitors include Tonix Pharma, Basking Biosciences and Neuraptive.
DeckTherapeutics offers THDG3.